Niels Wheeler

Join us in Amsterdam or virtually on 31 Oct for "Building a Biotech: Launching and Growing Your Start-up Company." Gain insights from J&J experts and guest speakers on funding, R&D, and more. Don’t miss out–register now: jji.jnj/3zpk1Lb

During drug discovery and development, it is vital to already consider how your product might benefit patients. Read about the importance of ascertaining early how to add value in the future marketplace. jji.jnj/3V1rCYs

Does the due diligence process seem daunting? Don’t miss this chance to get insights from industry experts on how to and set your start-up up for collaboration success! Register through: jji.jnj/4dtILAX #JNJInnovation #JLABS #JJIEvent

Calling all #biotech startups! Join us for a program designed to guide you through the complexities of first-in-human trials for biologics. Gain insights from J&J experts on Preclinical Development, CMC, Trial Design, & Regulatory Strategies. Register: jji.jnj/3uxNos2

Your IP strategy may influence opportunities for collaboration. How do you balance the common good of the project with your own interests? Join the hybrid program as different stakeholders share their insights. #Lifesciences #startups can register here: jji.jnj/3KxWSaN

Join us on 19 May as @AllenOvery provides a no-nonsense guide to key aspects of exits through M&A, focused on #lifesciences and #medtech #startups. In-person in Leiden or online: jji.jnj/exit-strategie…

Is your #lifesciences #startup looking to expand your team? Join the webinar on 3 March where different stakeholders will share insights in recruiting and retaining talent. jji.jnj/buildingyourte… #recruitment

“Time. It’s the single most valuable gift healthcare providers can give their patients.” Learn how the IDEA #QuickFireChallenge awardees aim to optimize detection of AL Amyloidosis for patients: jji.jnj/IDEA @JanssenGlobal

Is your #startup considering the needs of patients, partners, prescribers and payers in the development of your healthcare innovation? Innovators are invited to join as we discuss commercial considerations in discovery and early development. Register: jji.jnj/3jVgB8e

For any #startup or small company, non-dilutive #funding may become an essential component of a healthy #financing mix. Meet Bernd van Buuren from @protinhi and other speakers during this webinar & learn more! 🗓️ 14 October ⏰ 15:00-17:00 CEST ➡️ jji.jnj/3meVyxs